Yeh E - Search Results

1

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.

Giordano A, Liu Y, Armeson K, Park Y, Ridinger M, Erlander M, Reuben J, Britten C, Kappler C, Yeh E, Ethier S. Giordano A, et al. Among authors: yeh e. PLoS One. 2019 Nov 21;14(11):e0224420. doi: 10.1371/journal.pone.0224420. eCollection 2019. PLoS One. 2019. PMID: 31751384 Free PMC article.

2

Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-Negative Breast Cancer: Ligand-Mediated Mechanisms of Receptor Regulation and Potential for Clinical Targeting.

Williams CB, Soloff AC, Ethier SP, Yeh ES. Williams CB, et al. Adv Cancer Res. 2015;127:253-81. doi: 10.1016/bs.acr.2015.04.008. Epub 2015 May 8. Adv Cancer Res. 2015. PMID: 26093903 Review.

3

Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer.

Phelps-Polirer K, Abt MA, Smith D, Yeh ES. Phelps-Polirer K, et al. PLoS One. 2016 Apr 5;11(4):e0153025. doi: 10.1371/journal.pone.0153025. eCollection 2016. PLoS One. 2016. PMID: 27045589 Free PMC article.

4

Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase.

Zambrano JN, Williams CJ, Williams CB, Hedgepeth L, Burger P, Dilday T, Eblen ST, Armeson K, Hill EG, Yeh ES. Zambrano JN, et al. Oncotarget. 2018 Nov 13;9(89):35962-35973. doi: 10.18632/oncotarget.26311. eCollection 2018 Nov 13. Oncotarget. 2018. PMID: 30542510 Free PMC article.

5

Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer.

Rutkovsky AC, Yeh ES, Guest ST, Findlay VJ, Muise-Helmericks RC, Armeson K, Ethier SP. Rutkovsky AC, et al. BMC Cancer. 2019 May 23;19(1):491. doi: 10.1186/s12885-019-5667-4. BMC Cancer. 2019. PMID: 31122207 Free PMC article.

6

Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers.

Sun B, Mason S, Wilson RC, Hazard SE, Wang Y, Fang R, Wang Q, Yeh ES, Yang M, Roberts TM, Zhao JJ, Wang Q. Sun B, et al. Among authors: yeh es. Oncogene. 2020 Jan;39(1):50-63. doi: 10.1038/s41388-019-0953-9. Epub 2019 Aug 28. Oncogene. 2020. PMID: 31462705 Free PMC article.

7

HUNK phosphorylates EGFR to regulate breast cancer metastasis.

Williams CB, Phelps-Polirer K, Dingle IP, Williams CJ, Rhett MJ, Eblen ST, Armeson K, Hill EG, Yeh ES. Williams CB, et al. Oncogene. 2020 Jan;39(5):1112-1124. doi: 10.1038/s41388-019-1046-5. Epub 2019 Oct 9. Oncogene. 2020. PMID: 31597954 Free PMC article.

8

Correction: HUNK phosphorylates EGFR to regulate breast cancer metastasis.

Williams CB, Phelps-Polirer K, Dingle IP, Williams CJ, Rhett MJ, Eblen ST, Armeson K, Hill EG, Yeh ES. Williams CB, et al. Oncogene. 2021 May;40(20):3635-3636. doi: 10.1038/s41388-021-01797-3. Oncogene. 2021. PMID: 33958726 Free PMC article. No abstract available.

9

HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer.

Ramos Solis N, Cannon A, Dilday T, Abt M, Oblak AL, Soloff AC, Kaplan MH, Yeh ES. Ramos Solis N, et al. Oncoimmunology. 2024 Jun 5;13(1):2364382. doi: 10.1080/2162402X.2024.2364382. eCollection 2024. Oncoimmunology. 2024. PMID: 38846083 Free PMC article.

10

Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.

Yeh ES, Abt MA, Hill EG. Yeh ES, et al. Breast Cancer Res Treat. 2015 Jan;149(1):91-8. doi: 10.1007/s10549-014-3227-9. Epub 2014 Dec 17. Breast Cancer Res Treat. 2015. PMID: 25515931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

858 results

Search Page

Filters